Business ❯ Pharmaceuticals

AstraZeneca

Financial Performance Investment Vaccine Development Investments Research and Development Costs Legal Settlements Technology Advancements Growth Strategy Innovation Merger Vaccine Work Market Strategy Production Revenue Growth New Medicines Products Corporate Strategy Acquisition US Market Investment Decisions Vaccine Withdrawal Stock Market Expansion

Enhertu Improves Progression‑Free Survival in Phase 3 HER2‑Mutant Lung Cancer Trial

The topline result could lead AstraZeneca and Daiichi Sankyo to seek regulatory approval to use the drug as first‑line therapy.

Texas Wins Nearly $34 Million From AstraZeneca Over Alleged Medicaid Kickbacks

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion